Schedule 13G Filing for Purple Biotech Ltd.

This Schedule 13G filing is submitted by Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC, collectively referred to as the Reporting Persons. The filing discloses their beneficial ownership of 9.99% of Purple Biotech Ltd.'s ordinary shares, totaling 139,632,475 shares. The shares include those held directly by Intracoastal Capital LLC and those issuable upon the exercise of warrants. The filing also outlines the blocker provisions in the warrants that prevent the Reporting Persons from exceeding the 9.99% ownership threshold. The principal business offices of the Reporting Persons are located in Delray Beach, Florida, and Oak Park, Illinois. The filing is made pursuant to Rule 13d-1(c) and includes a joint filing agreement.